BioSpace News Archive

Quanterix Corporation (NASDAQ: QTRX) , a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its financial results for second quarter 2020 after the close of trading on Tuesday, August 4, 2020. Company management will host a conference call at 5:00 p.m., ET to discuss Quanterix’ financial results and provide a business update. The call will be hosted by

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the 500th case performed with the FIREFLY® Pedicle Screw Navigation Guides technology in collaboration with Mighty Oak Medical.

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through Commercialization, announced that Deb Tatton, Senior Vice President, Global Clinical Operations, has been named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry.

Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Wednesday, August 26th at 9:00 am. During the call, Generex President & CEO Joe Moscato will discuss the company’s new venture in telemedicine and remote patient monitoring that will be deployed in co

Stryker announced today that it has received U.S. Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation. Aneurysms in the posterior circulation rupture more

Eurofins Discovery, the leading provider of services and products to the drug discovery industry, announces publication of “The Activities of Drug Inactive Ingredients on Biological Targets” by Pottel et. al., in Science.

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that it will release second quarter 2020 results after the market close on Monday, August 10, 2020 and host a conference call at 4:30 p.m. ET to discuss second quarter 2020 results as well as to provide a general business update. Dial-in Number U.S. Dial-In: 877-300-8521 Int’l Dial

Largest study to date examines custodial grandparents from more than 80,000 households; shows children more likely to have social and behavioral problems

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, today announced it has signed a new three-year agreement with Pfizer Inc. to provide drug development services to advance Pfizer’s portfolio. Under the terms of the agreement, Pfizer has the right to extend the term for additional two-year periods. Financial details of the agreement were not disclosed. The agreement builds on the companies’ e

Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to detect and manage metabolic diseases, announced today Stephen A. Harrison, MD has joined its board of advisors.